News Releases
News Release
Oncolys and ASAHI INTECC CO. LTD. Announces Conclusion of Capital and Business Alliance
Oncolys BioPharma (headquartered in Minato-ku, Tokyo; Yasuo Urata, Representative CEO; hereinafter “Oncolys”) is pleased to announce that today the board of the company resolved to enter into a capital and business alliance agreement with Asahi Intecc Co., Ltd. (headquartered in Seto-city, Aichi Prefecture; Masahiko Miyata, President & CEO ;hereinafter “Asahi Intecc”), one of the world’s leading medical device producer specialized in guide wires and catheter products, to continue to maintain and strengthen the mutually rewarding relationship which both companies have built up in the clinical settings through exchanges of information concerning development of efficient and better medical devices for easier and more precise administration of oncolytic viruses regardless of locations of the affected area, since 2015 to date, and to further pursue to accelerate the mutual growth in the field of oncology.
Click here for details.
Click here for details.